The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and ...

Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on January 13, 2026, and ...

Cryotherapy Market OverviewThe Cryotherapy Market is projected to grow at a rate of around 7% by 2028, driven by rising incidences of sports injuries and cancer, continuous technological advancements, ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

As global markets navigate a complex landscape, Asian stocks remain a focal point for investors seeking opportunities beyond traditional boundaries. Penny stocks, despite their somewhat outdated ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that it will participate in and present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, ...

Medical advances transform care while industry tackles sustainability challenges and skilled worker shortages.

Apologies for the repost - our first version of this video appeared to exhibit some issues! 4K/144Hz monitors have really started to take off in the last 12 months, but they're still quite expensive.

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...